NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, TO US PERSONS OR INTO OR WITHIN
THE COMMUNICATION OF THIS ANNOUNCEMENT AND ANY OTHER DOCUMENTS OR MATERIALS RELATING TO THE RETAIL OFFER AS A FINANCIAL PROMOTION IS ONLY BEING MADE TO, AND MAY ONLY BE ACTED UPON BY, THOSE PERSONS IN THE
Fundraise and Strategic Investor
Concurrent with the Subscription, and to enable other shareholders of the Company to have an opportunity to subscribe for additional ordinary shares in the capital of the Company ('Ordinary Shares'), the Company is proposing to raise up to
The Subscription and Retail Offering (together the 'Fundraise') are conditional on (amongst other matters): (i) the provision of a title opinion on the Company's assets in
A Notice of Extraordinary General Meeting of the Company is to be posted to shareholders shortly. The Extraordinary General Meeting will be held at
Details of the Fundraise
The Subscription comprises a strategic investment by
For the avoidance of doubt, completion of the Retail Offering is conditional upon completion of the Subscription. Completion of the Subscription is not conditional on the Retail Offering (or any take up of the Retail
The Company will publish an announcement regarding the Retail Offering and its terms. The Retail Offering will not be underwritten.
The Issue Price of
Following completion of the Fundraise, Eagle Eye will hold a maximum of 29.90% of the enlarged issued share capital of the Company and the precise amount of the Subscription will be adjusted to reflect take-up of the Retail
Use of proceeds
The net proceeds of the Fundraise will principally be used to advance Cora's flagship
"With a robust Definitive Feasibility Study completed in Q3 2025 and a clear execution pathway in place, the Company is well positioned to unlock the next phase of value at Sanankoro.
"In parallel, permitting continues to progress well, supported by ongoing constructive engagement with the
"We are pleased to be in discussions with the Company on a fully funded project finance solution, which we believe would meaningfully de-risk the transition to construction and production, and support the delivery of long-term value for shareholders."
Posting of Circular and Extraordinary General Meeting
A circular containing further details of the Fundraise and convening an Extraordinary General Meeting of the Company to seek shareholder approval to provide authority for the issue of the New Ordinary Shares will be posted to shareholders shortly. A copy of the Notice of Extraordinary General Meeting will be made available on the Company's website (www.coragold.com). The Extraordinary General Meeting is expected to be held at
Relationship Agreement
Following the issue of the New Ordinary Shares, it is anticipated that Eagle Eye will be the Company's largest shareholder. The Company has entered into a Relationship Agreement with Eagle Eye to regulate the relationship between Eagle Eye and the Company on an arm's length and normal commercial basis. Pursuant to the agreement, Eagle Eye is entitled to appoint one non-executive director to the board of directors of Cora. In the event that Eagle Eye's shareholding falls below 10% the Relationship Agreement will terminate.
Proposed Board Change
Upon completion of the Fundraise, it is intended that
Adviser
Market Abuse Regulation ('MAR') Disclosure
Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014, which is part of
**ENDS**
For further information, please visit http://www.coragold.com or contact:
|
|
|
|
|
|
Cavendish |
+44 (0)20 7220 0500 |
|
|
|
+44 (0) 207 907 8500 |
|
Susie Geliher |
|
Notes
Cora is a West African gold developer with de-risked project areas within two known gold belts in
Cora has a Probable Reserve of 531 koz at 1.13 g/t Au (
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the